CRB Named ISPE Company of the Year
The Kansas City-based firm becomes the first to win the prestigious pharmaceutical engineering award four times.
Updated on Oct. 28, 2026 in Healthcare
The International Society for Pharmaceutical Engineering has named CRB its 2026 Company of the Year. This achievement makes the Kansas City-based firm the first company to ever receive the honor four times.
Why it matters
The award recognizes CRB for its commitment to advancing technical best practices and knowledge in the global pharmaceutical manufacturing industry. By securing the title again, the firm reinforces its role as a leader in providing engineering and construction solutions for life sciences.
CRB has received the ISPE Company of the Year award four times, following previous honors in 2000, 2012, and 2019. It remains the first professional services firm to ever receive this specific industry recognition.
The players
CRB
This Kansas City-based firm provides architecture, engineering, construction, and consulting solutions to the global life sciences and food and beverage industries.
International Society for Pharmaceutical Engineering
This organization is a global non-profit that provides technical and scientific knowledge to pharmaceutical manufacturing professionals.
The details
CRB provides comprehensive engineering, architecture, construction, and consulting solutions tailored for the food, beverage, and life sciences sectors. The organization received the latest honor during the society's annual meeting in Washington, D.C.
Timeline
CRB won the ISPE Company of the Year award in 2000.
CRB won the ISPE Company of the Year award in 2012.
CRB won the ISPE Company of the Year award in 2019.
The 2026 ISPE Annual Meeting and Expo took place on October 28, 2026.
Market Landscape
By securing its fourth ISPE Company of the Year award, CRB cements its standing as a dominant provider of technical services within the pharmaceutical manufacturing sector. This unprecedented win highlights the firm's capacity to consistently set benchmarks for industry best practices.
Clients in the life sciences sector may view this repeated recognition as a indicator of consistent performance standards in large-scale construction and engineering projects. For those relying on pharmaceutical manufacturing infrastructure, this award suggests the firm maintains high technical benchmarks.
The takeaway
The firm's repeated recognition by an international governing body serves as a strong signal of reliability for partners in the highly regulated pharmaceutical sector. Consistent industry honors often reflect a focus on long-term institutional knowledge that can benefit clients over decades of work.
Further reading
For more on industry developments in the area, visit the Kansas City healthcare.
Source note: This article includes information reported by The Manila times.
